SCHEMBL2039690

SCHEMBL2039690

CCOc1cc2c(cc1OC)C(c1ccc(C(=O)OC)cc1)=N[C@@H]1CCS(=O)(=O)C[C@H]21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.58
PDE4A P27815 2/20 0.58
PDE4B Q07343 2/20 0.58
PDE4C Q08493 2/20 0.58
L3MBTL1 Q9Y468 4/20 0.38
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 2/20 0.35
RECQL P46063 2/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 3/20 0.35
TSHR P16473 2/20 0.35
TP53 P04637 2/20 0.35
NPC1 O15118 1/20 0.35
USP2 O75604 1/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2047426 0.93 PDE4D (0.59) PDE4DPDE4APDE4BPDE4CL3MBTL1
SCHEMBL13721531 0.91 PDE4D (0.58) PDE4DPDE4APDE4BPDE4CL3MBTL1
SCHEMBL4187035 0.88 PDE4D (0.75) PDE4DPDE4APDE4BPDE4CL3MBTL1
SCHEMBL16286621 0.86 PDE4D (0.52) PDE4DPDE4APDE4BPDE4CL3MBTL1
SCHEMBL13721265 0.84 PDE4D (0.59) PDE4DPDE4APDE4BPDE4CL3MBTL1
SCHEMBL6386266 0.84 PDE4D (0.57) PDE4DPDE4APDE4BPDE4CL3MBTL1
Hydrochloric Acid SCHEMBL7207684 0.84 PDE4D (0.78) PDE4DPDE4APDE4BPDE4CL3MBTL1
SCHEMBL13721005 0.84 PDE4D (0.55) PDE4DPDE4APDE4BPDE4CL3MBTL1
Hydrochloric Acid SCHEMBL7207679 0.84 PDE4D (0.78) PDE4DPDE4APDE4BPDE4CL3MBTL1
SCHEMBL13721007 0.84 PDE4D (0.55) PDE4DPDE4APDE4BPDE4CL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2813509-B1 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4,3-c]isoquinoline derivatives ASTRAZENECA AB (SE) 2017-02-01 EP disclosed
US-9018175-B2 3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives TAKEDA GMBH (DE) 2015-04-28 US disclosed
EP-2813509-A1 3,4,4a,10b-tetrahydro-1h-thiopyrano-[4,3-c]isoquinoline derivatives Takeda GmbH (DE) 2014-12-17 EP disclosed
EP-2513119-B1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-C]ISOQUINOLINE DERIVATIVES TAKEDA GMBH (DE) 2014-06-25 EP disclosed
US-20120289474-A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES NYCOMED GMBH (DE) 2012-11-15 US disclosed
EP-2513119-A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c]ISOQUINOLINE DERIVATIVES Nycomed GmbH (DE) 2012-10-24 EP disclosed
WO-2011073231-A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES NYCOMED GMBH (DE) 2011-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289474-A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES PDE4A, PDE4B, PDE3B PDE4D 8/4885PDE4A 1/4885PDE4B 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.